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Abstract
Metabolic markers of baseline brain oxygenation and tissue perfusion have an important role to
play in the early identification of ischaemic tissue in acute stroke. Although well established MRI
techniques exist for mapping brain perfusion, quantitative imaging of brain oxygenation is
poorly served. Streamlined-qBOLD (sqBOLD) is a recently developed technique for mapping
oxygenation that is well suited to the challenge of investigating acute stroke. In this study a non-
invasive serial imaging protocol was implemented, incorporating sqBOLD and arterial spin label-
ling to map blood oxygenation and perfusion, respectively. The utility of these parameters was
investigated using imaging based definitions of tissue outcome (ischaemic core, infarct growth
and contralateral tissue). Voxel wise analysis revealed significant differences between all tissue
outcomes using pairwise comparisons for the transverse reversible relaxation rate (R20), deoxy-
genated blood volume (DBV) and deoxyghaemoglobin concentration ([dHb]; p < 0.01 in all
cases). At the patient level (n = 9), a significant difference was observed for [dHb] between
ischaemic core and contralateral tissue. Furthermore, serial analysis at the patient level (n = 6)
revealed significant changes in R20 between the presentation and 1 week scans for both ischae-
mic core (p < 0.01) and infarct growth (p < 0.05). In conclusion, this study presents evidence
supporting the potential of sqBOLD for imaging oxygenation in stroke.
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1 | INTRODUCTION
Ischaemic stroke is characterised by restricted blood supply to regions of
tissue that may ultimately result in infarction. However, the brain can tol-
erate a limited reduction in perfusion if tissue oxygenation levels can be
preserved. Therefore, techniques to map brain oxygenation in the acute
phase of stroke may help to identify viable tissue that requires interven-
tion to minimise the final infarct volume (Astrup, Siesjö, & Symon, 1981).
While Positron Emission Tomography (PET) is the current benchmark for
imaging oxygen metabolism in acute stroke (Ackerman et al., 1981;
Baron, 1999), it is not widely available in acute clinical settings.
Magnetic resonance imaging (MRI) is already widely used in the
assessment of patients with acute stroke and has the potential to be a
viable alternative to PET in measuring oxygen metabolism. Such mea-
surements are made possible by the inherent sensitivity of the trans-
verse MR relaxation rate (R2*) to deoxyhaemoglobin. R2* (= R2 + R20)
is composed of the irreversible (R2) and reversible (R20) transverse
relaxation rates with respect to a spin echo. As changes in R2 (and
hence R2*) are known to be affected by numerous factors aside from
tissue oxygenation (An et al., 2012; An et al., 2014), R20 is predicted to
have better specificity to baseline brain oxygenation (Yablonskiy &
Haacke, 1994). This sensitivity has previously been exploited to dem-
onstrate that alterations in R20 are indicative of the final outcome of
ischaemic tissue (Bauer et al., 2014; Geisler et al., 2006; Seiler et al.,
2012; Siemonsen et al., 2008; Zhang, Zhang, & Chen, 2011). However,
R20 is dependent on both deoxyhaemoglobin concentration ([dHb])
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and the DBV (Yablonskiy, 1998), resulting in ambiguity regarding the
physiological origin of a measured R20 alteration. The ability to sepa-
rate [dHb] from R20 would provide a quantitative physiological metric
directly related to tissue oxygenation, and to achieve this, knowledge
of the underlying DBV is required.
Dynamic susceptibility contrast (DSC) MRI has been used to
improve the physiological interpretation of R20 by providing cerebral
blood volume (CBV) and cerebral blood flow (CBF) information allow-
ing [dHb] to be estimated (Christen, Schmiedeskamp, Straka, Bammer,
& Zaharchuk, 2012). These methods have previously been employed
to investigate acute stroke (Gersing et al., 2015; Seiler et al., 2017a;
Seiler et al., 2017b). However, DSC requires an exogenous contrast
agent, which may limit the frequency with which scanning can be
repeated and be contraindicated in some patients (Gulani, Calamante,
Shellock, Kanal, & Reeder, 2017). In addition, DSC provides an esti-
mate of the blood volume across all vascular compartments, while
qBOLD requires a measurement of the volume occupied specifically
by deoxygenated blood.
There are noncontrast based alternatives that allow the estima-
tion of DBV and CBF. The quantitative-BOLD (qBOLD) method is able
to measure DBV by modelling the transverse MR signal decay in the
presence of a vascular network (An & Lin, 2000; He & Yablonskiy,
2007). Arterial spin labelling (ASL) can be used to quantify CBF by
inverting the magnetisation of arterial blood to act as a diffusible tracer
(Alsop et al., 2015). These endogenous methods are particularly suit-
able for application in acute stroke as they can be acquired noninva-
sively in a clinically relevant manner (An et al., 2015; Lee et al., 2003).
Recently we proposed a refinement of the qBOLD method tar-
geted at minimising confounding effects during data acquisition,
rather than by postprocessing, which we term streamlined-qBOLD
(sqBOLD; Stone & Blockley, 2017). By minimising the influence of nui-
sance signals (macroscopic field inhomogeneities, MFIs; cerebral spinal
fluid, CSF; and R2-weighting) during image acquisition the application
of the qBOLD model is simplified, improving the robustness of the
resultant oxygenation maps. While measurements in healthy young
subjects look promising, so far measurements have not been per-
formed in more challenging clinical research applications. The aim of
this study is to investigate the potential of sqBOLD to monitor
regional changes in brain oxygenation following ischaemic stroke, and
its relation to tissue outcome over time in a cohort of patients under-
going serial non-contrast multi-modal MR imaging, including ASL per-
fusion imaging.
2 | MATERIALS AND METHODS
2.1 | Patients
Patients with ischaemic stroke were recruited into a prospective
observational cohort study regardless of age or stroke severity under
research protocols agreed by the UK National Research Ethics Service
committees (ref: 13/SC/0362). The following inclusion criteria were
used to select patients for this analysis: DWI (b = 1,000 s/mm2) lesion
on the presenting scan and a follow up scan at either 24 hr or, prefer-
ably, 1 week following the initial scan to enable the definition of the
regions of interest. Patients with lacunar stroke, as defined on DWI
scan (lesions <15 mm in diameter), were excluded from this analysis.
Nine patients met the criteria to be included in this analysis (Table 1).
The median symptom onset to MRI time was 13 hr 49 min (range
2 hr 20 min – 1 day 4 hr 19 min, Table 1). Where possible, follow-up
scanning was performed at 2 hr, 24 hr, 1 week, and 1 month relative
to the presentation scan.
2.2 | Image acquisition
Scanning was performed on a Siemens 3T Verio scanner (Siemens
Healthineers, Erlangen, Germany) for all time points. The scanning
protocol included the MRI techniques described in the following
paragraphs.
Diffusion weighted imaging (DWI) with apparent diffusion coeffi-
cient (ADC) calculation was used to identify areas of cerebral ischae-
mia based on restricted diffusion caused by cell swelling (Le Bihan
et al., 2001) (three directions, 1.8 × 1.8 × 2.0 mm, field of view =
240 mm2, four averages, b = 0 and 1,000 s/mm2, TR/TE = 9,000/
98 ms, 50 slices, 2 min 53 s).
A T1-weighted (T1w) MP-RAGE was used for structural imaging
and image registration (1.8 × 1.8 × 1.0 mm, field of view = 228 mm,
TR/TE = 2040/4.55 ms, TI = 900 ms, 192 slices, scan duration
3 min 58 s).
TABLE 1 Patient characteristics
Patient
Stroke
syndrome Hemisphere Sex Age NIHSS Thrombolysed
Onset to
scan Follow-up scans
Voxels in ROI
(core, growth)
Mean
motion
score
P01 PACS Right F 69 6 Y 00:10:52 1 week, 1 month 59, 38 0.17
P02 POCS Left M 68 3 Y 00:04:11 2 hr, 1 week, 1 month 8, 49 0.18
P03 TACS Left M 79 14 Y 00:02:20 24 hr 1264, 2270 0.56
P04 POCS Left M 68 12 Y 00:19:33 24 hr 94, 225 0.62
P05 PACS Right M 78 4 N 01:04:19 24 hr (38 hr), 1 month 560, 167 2.12
P06 PACS Right M 87 19 Y 00:13:49 24 hr, 1 week 190, 97 0.20
P07 TACS Left M 77 22 Y 00:13:05 24 hr, 1 week 675, 5,725 0.24
P08 TACS Right F 74 10 Y (+ thrombectomy) 00:22:17 24 hr, 1 week 61, 688 0.44
P09 TACS Right F 80 17 Y 00:17:50 24 hr, 1 week 3237, 1619 0.13
NA = not available; NIHSS = National Institute of Health Stroke Scale; PACS = partial anterior circulation stroke; POCS = posterior circulation stroke;
TACS = total anterior circulation stroke.
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A T2-weighted FLAIR turbo spin echo was used to identify infarc-
tion on follow-up scans (Harston et al., 2017) (1.9 × 1.9 × 2.0 mm, field
of view = 240 × 217.5 mm2, TR/TE = 9,000/96 ms, TI = 2,500 ms,
58 slices, scan duration 2 min 8 s).
Vessel encoded Pseudo-Continuous Arterial Spin Labelling (PCASL)
was used for perfusion imaging and CBF calculation (Okell, Chappell,
Kelly, & Jezzard, 2013; EPI readout, 3.4 × 3.4 × 4.5 mm, field of view =
220 × 220 mm, 24 slices, TR/TE = 4,080/14 ms, labelling duration =
1.4 s, postlabelling delays = 0.25, 0.5, 0.75, 1, 1.25, and 1.5 s, scan
duration 5 min 55 s). Performing ASL with multiple postlabelling delays
improves absolute quantification of CBF in the presence of delayed
blood arrival times (Harston et al., 2017; Okell et al., 2013; Wang et al.,
2013). This is in contrast to DSC perfusion weighted imaging (PWI)
where prolonged time to peak (TTP) or mean transit time (MTT) are
commonly used to define hypoperfused tissue, rather than CBF.
A FLAIR-GASE acquisition was used to measure baseline brain
oxygenation using the sqBOLD approach (Stone & Blockley, 2017)
(96 × 96 matrix, field of view = 220 mm2, nine 5 mm slabs consisting
of four 1.25 mm sub-slices, 100% partition oversampling, 1 mm slice
gap, TR/TE = 3,000/82 ms, TIFLAIR = 1,210 ms, ASE-sampling scheme
τstart/τfinish/Δτ = −16/64/8 ms, scan duration 4 min 30 s). FLAIR-
GASE consists of three separate components, nulling of CSF partial
volumes using FLuid Attenuated Inversion Recovery (FLAIR; Hajnal
et al., 1992), direct measurement of R20 using an asymmetric spin echo
(ASE; Wismer et al., 1988) and minimisation of MFI using gradient
echo slice excitation profile imaging (GESEPI; Yang, Williams,
Demeure, Mosher, & Smith, 1998). The GESEPI technique compen-
sates for residual magnetic field gradients (MFGs) in the slice direction
that are not corrected by the manufactuer's standard 3D volume shim
(Gruetter & Boesch, 1992). This is achieved by oversampling in the
slice direction using a 3D acquisition. It has recently been shown that
by combining GESEPI with the ASE technique (GASE) the effect of
MFGs can be minimised in the majority of the brain (Blockley & Stone,
2016). However, GASE can only compensate MFGs below a critical
threshold. Hence positioning of the imaging volume was focussed on
the ischaemic region and slices were angeled away from areas of
severe MFI. The combined FLAIR-GESEPI-ASE (FLAIR-GASE) acquisi-
tion reduces confounding effects and when combined with quantita-
tive modelling offers a streamlined qBOLD approach.
2.3 | Post-processing
All image analysis was performed using the Oxford Centre for Func-
tional MRI of the Brain (FMRIB) Software Library (FSL) (Jenkinson,
Beckmann, Behrens, Woolrich, & Smith, 2012) and MATLAB
(Mathworks, Natick, MA). Post-processing details of VEPCASL data
to produce CBF maps have previously been described (Harston,
Okell, et al., 2017; Okell et al., 2013).
For sqBOLD, preprocessing and parameter map calculation from
the FLAIR-GASE data is based on previously described methods
(Stone & Blockley, 2017). In brief, the four 1.25 mm slices of each slab
were averaged to produce a single 5 mm slice. The τ-series was
motion corrected using the FSL linear motion correction tool
(MCFLIRT; Jenkinson, Bannister, Brady, & Smith, 2002) to the spin-
echo image. As an indicator of the severity of head-motion that
occurred during FLAIR-GASE acquisition, the mean relative root mean
square value was output from MCFLIRT, and henceforth described as
the mean motion score. The spin-echo image was brain extracted using
the FSL brain extraction tool (BET; Smith, 2002) to create a binary mask
of brain tissue and all remaining τ-weighted volumes were brain
extracted using this mask. The data were spatially smoothed using a
Gaussian kernel with a full-width half-maximum that matched the in-
plane resolution (2.3 mm). This smoothing was chosen to reduce the
impact of noisy voxels on the model fit without unduly reducing the
spatial resolution of the resulting parameter maps.
Oxygenation parameters R20 , DBV and [dHb] were directly
inferred from the sqBOLD data using the qBOLD model (Yablonskiy,
1998). To describe this model in simple terms, the mono-exponential
part of the signal decay (τ > 15 ms) is used to measure R20 and the
mismatch between a measured spin echo (τ = 0 ms) and the linear
intercept of the mono-exponential regime provides an estimate of the
DBV. The ratio of R20 and DBV is proportional to [dHb] (Equation 2).
To estimate sqBOLD oxygenation parameters for each voxel, R20 and
DBV were organised into a vector of unknowns (x) in a linear system
(A  x = B; Equation 1). S(τ) is the signal intensity of a given voxel for
a spin-echo displacement time (τ) and τ1,2, … n refers to the range
of spin-echo displacement times acquired in the long τ regime
(τ > 15 ms; Yablonskiy & Haacke, 1994). In this study τ values of
16, 24, 32, 40, 48, 56, and 64 ms were used. The first row of matrix
A describes where τ = 0, which is insensitive to DBV.
0 0 1
1 − τ1 1
1 − τ2 1
..
. ..
. ..
.
1 − τn 1
2
66666664
3
77777775
DBV
R2
0
log S0ð Þ− TE  R2
2
64
3
75 =
log S 0ð Þð Þ
log S τ1ð Þð Þ
log S τ2ð Þð Þ
..
.
log S τnð Þð Þ
2
66666664
3
77777775
ð1Þ
The weighted least squares solution was then used to produce
voxel-wise estimates and standard deviation of R20 and DBV. The
model fit was inversely weighted for τ, with data being acquired at
higher values of τ receiving less weighting in the fit, due to the
increasing contribution of noise with increasing signal decay. This
helps to account for the lower SNR in data acquired at longer τ-values
(Stone & Blockley, 2017). Parameter maps of [dHb] were calculated
using Equation 2, where DBV and R20 were estimated as above and
other parameters are known or assumed constants (Δχ0 = 0.264 ×
10−6 (He & Yablonskiy, 2007), κ = 0.03 (McPhee & Hammer, 2009)).
dHb½  = 3:R2
0
DBV  4  γ  π  Δχ0  κ  B0
ð2Þ
Estimating [dHb] negates the requirement for an assumed or
measured haematocrit, which is required in order to estimate the oxy-
gen extraction fraction (OEF). The standard deviation of [dHb] was
calculated by propagating the standard deviations calculated for R20
and DBV.
2.4 | Regions of interest
Binary masks of the presenting lesion were automatically generated
by thresholding maps of ADC at 620 × 10−6 mm2/s (Purushotham
et al., 2015). Initial clustering was performed using the FSL Cluster
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tool (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/Cluster). The ROI cluster was
identified and smoothed (Gaussian kernel of standard deviation
1 mm) and followed by repeat cluster analysis. The small amount of
smoothing applied to the initial binary cluster mask was performed to
remove isolated noisy voxels during repeat clustering, resulting in bet-
ter specificity of the ADC ROI to the presenting lesion. These auto-
mated ADC masks were inspected by a clinician to ensure their
accuracy and manually corrected when necessary (Harston et al.,
2015). An independent observer manually defined the final infarct
ROI. This was preferentially performed using the 1-week T2-FLAIR
image or, if unavailable, the 24 hr b = 1,000 s/mm2 DWI image
(Harston, Minks, et al., 2017).
The following tissue outcomes were used in the analysis and were
defined from the infarct ROIs in the native space of the sqBOLD and
ASL parameter maps.
• The ischaemic core is tissue common to both the presenting ADC
lesion and final infarct.
• Infarct growth is tissue present in the final infarct that is not pre-
sent in the presenting ADC lesion.
• The contralateral tissue is defined by a composite mask of the
presenting and final infarct tissue mirrored to the contralateral
side of the brain.
2.5 | Registration
Registration of imaging modalities within a single time point was
achieved using rigid body registration (6 degrees of freedom [DOF])
(Jenkinson & Smith, 2001). Between time point registration was per-
formed using nonlinear registration of the T1-weighted structural
scans to limit potential error introduced by edema (Harston, Minks,
et al., 2017). To create contralateral ROIs, the infarct masks were
mirrored in standard space following nonlinear registration of the T1-
weighted image to a standard atlas (MNI152; Mazziotta et al., 2001).
At each time point, the FLAIR-GASE spin-echo image (τ = 0 ms) was
registered (6 DOF) to the T1-structural using the b = 0 s/mm
2 DWI
image as an intermediate registration step. For the ASL data, an
unsubtracted reference volume was registered (6 DOF) directly to
the T1-structural image.
2.6 | Regional analysis
For the MRI data acquired during presentation and follow-up scan-
ning, voxel values of R20, DBV, [dHb], and CBF were extracted from
the native space of the acquired parameter maps using the ROI defini-
tions of ischaemic core, infarct growth and contralateral tissue.
A voxel-level analysis of the presenting imaging data was con-
ducted by pooling voxel values of R20 , DBV, and [dHb] across all
patients for each tissue outcome ROI. This analysis enables the sensi-
tivity of the sqBOLD parameters to different tissue outcomes. For
each parameter (R20, DBV, and [dHb]), differences between the voxel-
value-distributions from the tissue outcome ROIs on presentation
(ischaemic core, infarct growth, and contralateral tissue) were tested.
To test the null hypothesis of no difference between the voxel-value-
distributions from the tissue outcome ROIs a Kruskal–Wallis test was
used. The Kruskal–Wallis test is a version of the classical one-way
ANOVA that does not require the assumption of normally distributed
data. This non-parametric test was chosen as the distribution of [dHb]
values in healthy grey matter have previously been found to be non-
normally distributed (Stone & Blockley, 2017). On rejecting the null
hypothesis, post hoc pairwise comparisons between the different tis-
sue outcome ROIs were performed using the Tukey–Kramer method
(honest significant difference test) to consider which pairs were signif-
icantly different. The Tukey–Kramer method controls for such multi-
ple comparisons.
A patient-level analysis of the presenting imaging data was con-
ducted by calculating the median R20, DBV, [dHb], and CBF for each
of the tissue outcome ROIs in each patient for presenting scans. For
the median values extracted across the patient group, the null hypoth-
esis of no difference between the three tissue outcomes was tested
using a two-way ANOVA. Again if the null hypothesis was rejected
for a given parameter, post hoc pairwise comparisons were performed
using the Tukey–Kramer method.
To aid the development of suitably powered follow on studies,
the results of these experiments were used to calculate the effect size
for each measure. Cohen's d was chosen to measure the differences
between means when comparing each of the pairs of tissue outcome
ROIs. Since these data are paired, d was calculated from the mean dif-
ference and standard deviation of differences.
To investigate the evolution of sqBOLD parameters in follow-up
scans, the median R20, DBV, [dHb], and CBF were calculated for each
of the tissue outcome ROIs in each patient for the presenting and
1 week scans. Median parameter values in the ischaemic core and
infarct growth ROIs were normalised within scan to the contralateral
tissue ROI. Two tailed paired t-tests were performed to test the
hypothesis that the mean difference between time points is zero.
3 | RESULTS
3.1 | Group characteristics
Nine consecutive large volume stroke patients met the criteria for
inclusion in this analysis. The median National Institute of Health
Stroke Scale at presentation was 12 (range 3–22). Eight patients
received intravenous (IV) thrombolysis with one of those patients also
undergoing thrombectomy (Table 1). Infarct growth was observed
in all nine patients. Patient demographics, including details of the
number of voxels included in the ischaemic core and infarct growth
ROIs in the space of the FLAIR-GASE image space, are provided in
Table 1.
3.2 | Comparison of presentation scans and tissue
outcome
To demonstrate the potential of sqBOLD for quantitatively mapping
oxygenation in a clinical research setting, data acquired during the ini-
tial MRI scan session are displayed in Figure 1 for all patients (n = 9).
For each patient, oxygenation (sqBOLD) and blood flow (ASL) parame-
ter maps are presented alongside diffusion (DWI, b = 1,000 s/mm2)
images. Core (blue), growth (orange), and contralateral (yellow) tissue
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outcome ROIs are displayed on the sqBOLD spin-echo image. As a
measure of the error in the oxygenation parameters, maps of the stan-
dard deviation of R20 , DBV and [dHb] are provided. Higher error is
noticeable in patients with more severe head motion during acquisi-
tion. For example, patient P05 displays the highest mean motion score
and shows the largest standard deviation in the oxygenation parame-
ters compared with patient P09, who moved the least. The mean
motion scores estimated during motion correction for the presenta-
tion scans are listed in Table 1. It can also be seen that high DBV in
the ventricles coincides with high DBV standard deviation and a large
FIGURE 1 Data acquired during initial MRI scanning for all patients included in the study (n = 9). (a) DWI (b = 1,000 s/mm2), (b) asymmetric spin-echo
(τ = 0 ms), (c–h) sqBOLD oxygenation and (i) ASL blood flowmaps are presented for a single axial slice in each stroke patient. All images are presented
in their native acquisition space. Core (blue), growth (orange), and contralateral (yellow) tissue outcome ROIs are displayed on the spin-echo image of
the sqBOLD acquisition (b). Streamlined-qBOLD parameter maps (R20(c), DBV(e), and [dHb](g)) are presented alongside standard deviations on the
parameter estimates calculated from the least-squares fitting for (d) R20, (f) DBV, and (h) [dHb] [Color figure can be viewed at wileyonlinelibrary.com]
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mean motion score. In contrast, regions of tissue generally show low
standard deviation across oxygenation parameters, which does not
appear to vary across tissue outcome ROIs. This demonstrates a bet-
ter fit to the qBOLD model (Equation 1) in these regions.
Figure 2 presents the voxel-level analysis as the median and inter-
quartile ranges of each tissue type at the presenting time point via
box and whisker plots (whisker length 1.5 × interquartile range, out-
liers outside the whisker length are not shown).
Each parameter (R20, DBV, and [dHb]), as measured at presentation,
differed significantly between the tissue outcome ROIs (Kruskal–Wallis
test, p < 0.001). Post hoc pairwise comparisons of each parameter in
the different ROIs (ischaemic core and contralateral tissue; infarct
growth and contralateral tissue; ischaemic core and infarct growth)
revealed differences between all ROIs for each parameter (p < 0.01 in
all cases). A more detailed voxel-level investigation of CBF in a similar
patient cohort has been published elsewhere (Harston, Okell,
et al., 2017).
Figure 3 presents the patient-level analysis of the presenting
imaging data. Group-average (mean ± standard deviation) baseline
brain oxygenation and perfusion measurements are shown for each of
the tissue outcome ROIs. A significant difference between tissue out-
comes was detected for [dHb] (two-way ANOVA, p < 0.0001), but
not for the other parameter maps (R20 , DBV, and CBF). Post hoc pair-
wise comparisons of the tissue outcomes for [dHb] revealed a signifi-
cant difference (p < 0.01) between ischaemic core and contralateral
tissue and between ischaemic core and infarct growth. However, the
patient-level measures demonstrate a heterogeneity of responses
across the group (Table 2). For example, both hypo- and hyperperfu-
sion was observed for measurements of CBF. The effect size was
greatest for [dHb] when making pairwise comparisons between each
of the tissue outcomes and the contralateral ROI (Table 3).
3.3 | Comparison of presentation and follow up
scans
The pertinent features of the sqBOLD technique as applied to acute
stroke are illustrated through four example patients (Figures 4–7).
Firstly, the use of sqBOLD to investigate brain oxygenation over multi-
ple time points is demonstrated in two patients and, secondly, two
important confounding effects are considered through further examples.
Lastly, the potential of serial imaging is investigated at the patient level
by comparing the presenting data with images acquired at 1 week.
The images in Figure 4 were acquired from patient P03 on pre-
sentation (2 hr 20 min postonset) and 24 hr after presentation. This
patient received IV thrombolysis at 1 hr 24 min post-onset. On pre-
sentation, a lesion is clearly evident on the b = 1,000 s/mm2 map. The
presenting R20 parameter map shows a large region of elevated R20 in
the area surrounding the presenting DWI lesion, which corresponds
to a region of reduced CBF in the presenting CBF map. At the follow
[s-1] [%] [g.dl-1]
Core Growth ContraCore Growth ContraCore Growth Contra
R2´ [dHb]DBV
0
12 8
0
20
0
FIGURE 2 Box and whisker plot showing voxel-level analysis of the tissue outcome from presenting time points. For each parameter (R20, DBV,
and [dHb]) at presentation, the null hypothesis was rejected suggesting that the voxel-value-distributions differed between the tissue outcome
ROIs (Kruskal–Wallis test, p < 0.001 in all cases). Post hoc multiple comparisons analysis showed statistically significant pairwise differences
between the tissue outcome ROIs (ischaemic core and contralateral tissue; infarct growth and contralateral tissue; ischaemic core and infarct
growth; p < 0.01 in all cases) for each parameter [Color figure can be viewed at wileyonlinelibrary.com]
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FIGURE 3 Patient-level, group average (± standard deviation)
parameters showing tissue outcome from presenting time points.
Using a two-way ANOVA the null hypothesis was rejected in the case
of [dHb] (p = 0.0001). Post hoc, multiple comparisons testing showed
a significant difference between [dHb] measured in the core
compared to growth (p = 0.0016) and core compared to contralateral
tissue (p = 0.0001). No significant difference was found between
[dHb] measured in growth and contralateral tissue (p = 0.3207) [Color
figure can be viewed at wileyonlinelibrary.com]
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up imaging time point (24 hr), the DWI lesion has grown to include
the region that was elevated on the presenting R20 parameter maps,
while the region of reduced CBF remains similar. Elevated R20 is indic-
ative of an increase in the presence of deoxyhaemoglobin in this
region, which is driven by increases in DBV and/or [dHb] as seen in
the accompanying parameter maps. In contrast to the large elevated
region of R20 there is also a region of reduced R20 that approximately
coincides with the presenting DWI lesion, which is indicative of a
reduced amount of deoxyhaemoglobin. Nevertheless, the median R20
extracted from the ischaemic core ROI, which is defined based on the
presenting DWI, is still greater than the infarct growth ROI (Table 2).
The measure of R20 in this region appears to decrease between the
presenting and follow-up imaging time points.
Figure 5 displays data from patient P01 on presentation (10 hr
52 min postonset) and at 1 week and 1 month after presentation.
This patient received IV thrombolysis at 2 hr 31 min post-onset. At
presentation, a well defined lesion is visible in the b = 1,000 s/mm2
images. This is paralleled by similarly well defined regions of elevated
R20 and reduced CBF. An elevation in DBV can also be seen. At
1 week R20 appears to have normalised, but now hyperperfusion is
seen where previously hypoperfusion had been present. Finally, CBF
is observed to be normalised by the 1 month scan.
Figure 6 shows images acquired from patient P05 who did not
receive IV thrombolysis and was scanned on presentation (28 hr
20 min postonset), with follow up scanning performed at 38 hr and
1 month after presentation. Elevated R20 is observed in regions
expected to contain CSF at presentation. This is consistent with a fail-
ure of the CSF nulling FLAIR preparation. This is most likely due to
patient motion since this patient recorded the highest mean motion
score of 2.12, which compares with the 1 month scan where CSF
signal appears nulled and a mean motion score of 0.86 was recorded.
Maps of CBF demonstrate a heterogenous pattern of perfusion in the
ischaemic region and appear to be relatively consistent between imag-
ing time-points.
Figure 7 shows images acquired from patient P06 scanned on
presentation (13 hr 49 min postonset), with follow up scanning per-
formed at 24 hr and 1 week after presentation. This patient received
IV thrombolysis at 3 hr 28 min post-onset. On presentation, there is
an obvious deep grey matter lesion on the affected side of the brain
that is clearly visible on the b = 1,000 s/mm2 image, which corre-
sponds with a region of elevated CBF compared with the mirrored
contralateral ROI. However, the presenting R20 parameter maps show
bilateral elevations in R20 on both the affected and unaffected sides,
although to a larger degree in the ischaemic core (Table 2). These deep
grey matter structures are known to have high iron content and the
presence of this iron causes an elevation in R20 that is unrelated to
oxygenation and confounds the oxygenation measurement that is
made within this region. Similarly, elevated R20 regions are also
observed in the growth ROI of patient P08, which is partially within
this deep grey matter region (Figure 1). This highlights the importance
of considering sources of susceptibility other than deoxyhaemoglobin
in the locality of the region of interest. Despite this [dHb] appears to
be elevated in the affected hemisphere compared with the unaffected
hemisphere (Table 2).
Figure 8 compares measurements made at presentation with those
made at the follow up scan at 1 week, which was available in 6 of the
9 patients. The null hypothesis was rejected for the R20 measurements in
the ischaemic core (paired t-test, p < 0.05) and infarct growth (paired
t-test, p < 0.01) ROIs. In both cases R20 is reduced at 1 week compared
with presentation, which is consistent with increased blood oxygenation.
This increase in blood oxygenation is mirrored in measurements of DBV
and [dHb], which both result in a nonsignificant reduction in the amount
of deoxyhaemoglobin present in the voxel.
4 | DISCUSSION
Streamlined-qBOLD is shown to provide metabolic information that is
indicative of tissue viability following acute stroke. Detailed regional
TABLE 2 Parameter map estimates for each patient and tissue outcome ROI at presentation
Patient
R20 (s
−1) DBV (%) [dHb] (g.DL−1) CBF (mL100g−1min−1)
Core Growth Contra Core Growth Contra Core Growth Contra Core Growth Contra
P01 5.3 5.1 3.2 7.2 6.5 3.7 2.7 2.6 2.2 9.3 12.8 58.8
P02 3.6 3.2 3.5 4.2 4.1 5.1 3.6 2.8 2.3 23.4 19.3 29.7
P03 5.1 4.7 3.2 6.9 7.0 3.1 2.7 2.3 2.0 11.1 14.8 37.5
P04 3.5 4.3 2.4 6.5 3.6 4.5 1.8 1.9 1.6 67.6 54.3 40.5
P05 8.4 9.6 4.1 2.7 3.4 1.3 1.1 1.0 0.5 16.0 22.0 17.3
P06 12.4 4.3 7.5 8.8 6.0 6.6 4.1 2.6 2.7 85.1 35.1 25.9
P07 3.3 2.4 2.3 4.2 3.9 2.9 2.6 1.9 1.6 110.8 53.2 44.7
P08 2.9 4.1 4.3 2.5 4.2 5.3 3.3 2.0 2.5 90.3 60.1 53.4
P09 3.9 2.8 2.1 5.3 3.6 4.1 2.4 1.7 1.3 77.5 61.8 74.2
Mean 5.4 4.5 3.6 5.4 4.7 4.1 2.7 2.1 1.9 54.6 37.1 42.5
SD 3.1 2.1 1.7 2.1 1.4 1.6 1.0 0.6 0.7 39.5 20.4 17.7
TABLE 3 Effect size between tissue outcome ROIs calculated using
Cohen's d to consider differences between means
Parameter Core vs. contra Core vs. growth Growth vs. contra
R20 0.92 0.31 0.39
DBV 0.57 0.02 0.38
[dHb] 2.12 1.14 0.64
CBF 0.31 0.74 0.28
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analysis demonstrates that R20 , DBV and [dHb] are sensitive to oxy-
genation related changes in tissues with varying outcomes, supported
by serial-imaging from example patient cases. Significant pairwise dif-
ferences in voxel distributions were observed between the regional
tissue ROIs using pairwise comparisons for R20, DBV, and [dHb]
(ischaemic core and contralateral tissue; infarct growth and
contralateral tissue; ischaemic core and infarct growth; p < 0.01 in all
cases). At the patient level, a significant difference between tissue
outcomes was only observed for [dHb], with pairwise comparisons
revealing this effect to be driven by a significant difference between
ischaemic core and both infarct growth and contralateral tissue. Fur-
thermore, serial analysis at the patient level revealed significant
FIGURE 5 DWI (b = 1,000 s/mm2), sqBOLD parameter maps (R20 , DBV, and [dHb]) and CBF maps are presented for a single axial slice in an
example patient. Core (blue), growth (orange), and contralateral (yellow) tissue outcome ROIs are displayed on the spin-echo image of the
sqBOLD acquisition. Patient P01 (female, 69 years old, NIHSS = 6, IV thrombolysis at 2 hr 31 min postonset) was scanned on presentation (13 hr
49 min postonset) and again at 24 hr and 1 week postinitial scan [Color figure can be viewed at wileyonlinelibrary.com]
FIGURE 4 DWI (b = 1,000 s/mm2), sqBOLD parameter maps (R20 , DBV, and [dHb]) and CBF maps are presented for a single axial slice in an
example patient. Core (blue), growth (orange), and contralateral (yellow) tissue outcome ROIs are displayed on the spin-echo image of the
sqBOLD acquisition. Patient P03 (male, 79 years old, NIHSS = 14, IV thrombolysis at 1 hr 24 min postonset) was scanned on presentation (2 hr
20 min postonset) and again at 24 hr [Color figure can be viewed at wileyonlinelibrary.com]
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changes in R20 between the presentation and 1 week scans for both
ischaemic core (p < 0.01) and infarct growth (p < 0.05).
4.1 | Ischaemic penumbra
The definition of the infarct growth region used in this study is
expected to be spatially and metabolically consistent with the fraction
of the ischaemic penumbra that does not survive. In this region, an
increase in [dHb] is anticipated in order to maintain the rate of oxygen
metabolism in tissue that is experiencing a reduction in CBF. The
potential of sqBOLD to detect these changes was demonstrated by
the statistically significant increase in [dHb] measured in the infarct
growth ROIs at the voxel level (Figure 2; p < 0.01). Furthermore,
[dHb] was found to be elevated, and CBF reduced, at the patient-
level, although this was not statistically significant (Figure 3). In addi-
tion to the observed changes in CBF and [dHb], DBV was found to be
elevated in the infarct growth region (Figure 3). In order to interpret
this it is important to understand the definition of DBV, which repre-
sents the blood volume occupied by deoxygenated blood. In healthy
tissue this is largely contained within the veins and capillaries and an
elevation would therefore normally result from passive inflation dur-
ing increases in CBF. Since CBF is reduced here, increases in DBV can
only be achieved by decreasing blood oxygenation in normally highly
oxygenated vessels, such as precapillary arterioles. These vessels have
already been shown to have a higher degree of desaturation than
previously thought (Vovenko, 1999) which could feasibly be further
reduced during ischaemia.
The spatial correspondence of the sqBOLD parameter maps with
the infarct growth ROI can also be observed at the individual patient
level (Figure 4). This example case shows presenting measures of R20,
DBV, and [dHb] that are elevated in regions that correspond to the
infarct growth ROI. The CBF parameter map acquired on presentation
demonstrates a large region of decreased flow that coincides with the
elevated regions on the sqBOLD parameter maps. A restriction in flow
is expected to result in an elevated OEF, which in turn causes an
increase in the relative amount of deoxyhaemoglobin produced. As
such, the observation of reduced CBF and elevated [dHb] in this
patient is suggestive of the early identification of tissue exhibiting the
physiological traits of the ischaemic penumbra. This opens up the
prospect that concurrent MR based oxygenation and flow imaging can
be used to identify tissue at risk of infarction (Astrup et al., 1981). In
this patient, infarction occurs in this region at some point between
the presenting and follow up scan times as evidenced by the infarct
growth ROI (defined from the b = 1,000 s/mm2 image). Therefore,
early identification of penumbral tissue would provide a window of
opportunity for interventions that might salvage this tissue.
4.2 | Ischaemic core
From Figure 2, it can be seen that increases in all of the baseline brain
oxygenation parameters are observed in the ischaemic core compared
to infarct growth on presentation. This trend appears surprising at
first, particularly if the elevated signal in the core is to be associated
with the presence of deoxyhaemoglobin as a by-product of ongoing
FIGURE 6 DWI (b = 1,000 s/mm2), sqBOLD parameter maps (R20 , DBV, and [dHb]) and CBF maps are presented for a single axial slice in an
example patient. Core (blue), growth (orange), and contralateral (yellow) tissue outcome ROIs are displayed on the spin-echo image of the
sqBOLD acquisition. Patient P05 (male, 78 years old, NIHSS = 4, no IV thrombolysis) was scanned on presentation (28 hr 20 min postonset) and
again at 38 hr and 1 month postinitial scan [Color figure can be viewed at wileyonlinelibrary.com]
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metabolism. The infarct growth region is expected to contain tissue
that is metabolically active on presentation but later recruited to the
final infarct volume. This is in contrast to the nonviable tissue present
in the ischaemic core. However, the elevated qBOLD signal measured
in the ischaemic core can be explained either as stationary deoxyhae-
moglobin in metabolically inactive regions with no blood supply or as
ongoing metabolism in the diffusion lesion. This also offers two possi-
ble scenarios that explain the significant increase in core [dHb] mea-
sured at the patient-level (Figure 3).
4.3 | Stationary deoxyhaemoglobin
A similar regional trend in R20 can be extrapolated from a previous
study (Geisler et al., 2006) which looked at comparable tissue out-
come ROIs. Here it was proposed that the elevated R20 in the ischae-
mic core may result from stationary deoxyhaemoglobin present in
vessels without blood supply. In the event of a complete occlusion of
flow, stationary haemoglobin beyond the blockage will become fully
deoxygenated as the remaining oxygen is metabolised leading to an
increase in the amount of deoxyhaemoglobin present. This is likely to
be the main contributing factor to the trend seen in Figure 2, where
the ischaemic core demonstrates the largest elevation in R20, DBV,
and [dHb]. In the context of the DBV elevation observed in the infarct
growth region this would similarly reflect the desaturation of arteriolar
blood vessels.
4.4 | Reperfusion
In contrast, R20 and [dHb] parameter maps in Figure 4 demonstrate a
decrease in the ischaemic core. This may be explained by the presence
or restoration of flow to an infarcted region. In this case, metabolically
inactive tissue would not produce new deoxyhaemoglobin and previ-
ously produced deoxyhaemoglobin would be removed by the restored
blood flow, leading to a decrease in R20, DBV, and [dHb]. This patient
received thrombolysis at 1 hr 24 min postonset. Despite this, flow is
still noticeably reduced in this patient in the ischaemic core at presen-
tation (Table 2) suggesting that recanalisation has not occurred. It is
unclear whether this flow is sufficient to clear the deoxyhaemoglobin
from metabolically inactive tissue.
4.5 | Ongoing metabolism in the diffusion lesion
Elevated [dHb] and DBV in the ischaemic core may also be explained by
observations made using PET, which have shown that regions of ongoing
oxygen metabolism are possible within the presenting diffusion lesion
(Fiehler et al., 2002; Guadagno et al., 2004, 2006; Kidwell et al., 2000).
As such, it is possible that deoxyhaemoglobin production may still be
occurring in regions of decreased ADC and contribute towards elevated
R20 in the ischaemic core. While none of the patients in this study clearly
demonstrate this phenomenon (ie, elevated R20 in the presence of non-
zero CBF), the parameter maps shown in Figure 6 show some evidence
of a heterogeneous pattern of blood oxygenation within the diffusion
lesion. Unfortunately, these parameter maps are of low quality due to
FIGURE 7 DWI (b = 1,000 s/mm2), sqBOLD parameter maps (R20 , DBV, and [dHb]) and CBF maps are presented for a single axial slice in an
example patient. Core (blue), growth (orange) and contralateral (yellow) tissue outcome ROIs are displayed on the spin-echo image of the sqBOLD
acquisition. Patient P06 (male, 87 years old, NIHSS = 19, IV thrombolysis at 3 hr 28 min postonset) was scanned on presentation (13 hr 49 min
postonset) and again at 24 hr and 1 week postinitial scan [Color figure can be viewed at wileyonlinelibrary.com]
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patient motion during the acquisition, particularly at the presenting time
point. Head motion can introduce noise into the ASE τ-series and can
result in the failure of the FLAIR CSF nulling preparation. This has the
potential to cause unreliable parameter fits. The impact of patient motion
is considered later in this section.
4.6 | Interpretability of [dHb] and OEF
It is evident that the relaxometry based method used in this study is
sensitive to deoxyhaemoglobin regardless of the patency of the blood
supply and can therefore exhibit elevated R20 in the ischaemic core. As
such, knowledge of the local blood supply is important to distinguish
stationary deoxyhaemoglobin present in infarcted tissue from active
tissue with an elevated metabolism. This motivated the calculation of
[dHb] rather than OEF to avoid the false interpretation of a high R20
as always representing elevated oxygen extraction. This sensitivity to
stationary deoxyhaemoglobin also reconciles the apparent differences
between PET and BOLD based measurements (Geisler et al., 2006). In
PET the oxygen sensitive tracer is prevented from being delivered to
the ischaemic core, meaning that signal is not detected there and
reduced oxygen metabolism is inferred. This is in contrast to BOLD
based measurements, which do not rely on the arrival of a tracer and
hence the presence of deoxyhaemoglobin will still cause an increase
in R20. However, in this study all of the patients with hypoperfused
lesions had nonzero median CBF in the ischaemic core ROI at presen-
tation (Table 2). It remains to be seen whether there is a threshold
CBF below which the blood is functionally stationary with respect to
the accumulation of deoxyhaemoglobin.
4.7 | Prospects for serial imaging of brain
oxygenation
Streamlined-qBOLD and ASL data were successfully acquired at each
of the time points listed in Table 1. Follow up time points were most
commonly missed due to patient or scanner unavailablility. Despite
this six out of the nine patients included in this study had a 1 week
follow up scan. Comparison of sqBOLD and ASL metrics between pre-
sentation and 1 week at the patient level was performed by normalis-
ing these ROI based measurements to the contralateral ROI at each
time point. This analysis revealed significant changes in R20 for ischae-
mic core and infarct growth regions. This likely reflects the greater
robustness of the R20 maps compared to the physiological maps of
DBV and [dHb] (Figure 1). Since R20 reflects the amount of deoxyhae-
moglobin present in the voxel, it can be seen that the decrease in
DBV and [dHb] is consistent with a decrease in R20. Likewise all three
metrics converge towards unity at 1 week, representing a normalisa-
tion of these tissue oxygenation parameters. Conversely measure-
ments of CBF become even greater than contralateral values at
1 week, representing increasing hyperperfusion.
4.8 | Confounds: Non-deoxyhaemoglobin related
elevations and patient-motion
Streamlined-qBOLD is sensitive to other sources of magnetic suscep-
tibility in the brain not related to deoxyhaemoglobin and care must be
taken when interpreting elevations in signal. Iron and myelin are
known sources of susceptibility that can confound the accurate quan-
tification of brain oxygenation with this method and are of particular
relevance as both can vary during ageing and in different pathologies.
Figure 7 shows bilateral elevations in R20 on both the affected and
unaffected sides of the brain due to the high iron content of the deep
grey matter structures. The presenting [dHb] map appears to be more
highly elevated in deep grey matter on the affected side, pointing
towards the importance of interpreting the R20, DBV, [dHb], and CBF
parameter maps in combination, as well as being aware of non-oxygen
related sources of susceptibility in the locality of the region of inter-
est. Furthermore, a change in local haematocrit level could influence
regional sqBOLD measurements (Broisat et al., 2018). For example, a
local increase in Hct would increase R20 even in the case of high CBF.
Significant head-motion during imaging is a challenge in acute
stroke patients. Despite the segmented nature of the FLAIR-GASE
acquisition, image artefacts were minimal. However, large head
motions did impact the accuracy of the FLAIR CSF suppression. Slice
selective inversion recovery pulses were used to optimise CSF sup-
pression for each slice. However, large head motions between this
FLAIR preparation and image acquisition resulted in ineffective
removal of the CSF signal. This is evident in the presentation parame-
ter maps in Figure 6, where elevated signal can be seen within the
ventricles, particularly in the R20 map. As the presence of CSF signal
can lead to apparent elevations in R20 not related to oxygenation, it
may obscure the oxygenation changes within the diffusion lesion on
presentation (Dickson, Williams, Harding, Carpenter, & Ansorge,
2009; He & Yablonskiy, 2007; Simon, Dubowitz, Blockley, & Buxton,
2016). However, it is encouraging that heterogeneous patterns of
oxygenation can be seen within the diffusion lesion at the follow-up
imaging time points where CSF suppression was effective. Further-
more, voxel-wise error maps demonstrate that the error calculated on
parameter estimates are considerably lower in tissue compared with
values in the ventricles, where high DBV can be observed in some
patients with high mean motion scores (Figure 1). This provides some
assurance of oxygenation measurements made in tissue even in cases
where there is significant head motion during sqBOLD acquisition.
Through patient-wise comparison of mean motion scores (Table 1)
and R20 standard deviation maps (Figure 1) it is noticeable that
patients with higher motion scores demonstrate larger standard devai-
tions in areas such as the ventricles and subarachnoid spaces, consis-
tent with a failure in CSF nulling. The impact of patient motion and
elevated motion score on the parameter maps is demonstrated in Fig-
ure 4. Regions of reduced DBV and CBF are noticeable in the larger
contralateral region on presentation. This is at least partially due to
motion artefact as evidenced by the relatively high mean motion score
(P03, Table 1). Although there are localised areas of decreased DBV
and CBF in the presenting contralateral ROI, the median values from
this region (P03, Table 1) are not unreasonably low.
From Figure 5 a noticeable increase in DBV can be seen between
the presentation and 1 week follow-up scans. On closer inspection,
the 1 week DBV error map (data not shown) appears uniformly ele-
vated compared to presentation. Further inspection of this data,
which was found to have a low mean motion score, indicates that
patient motion was not a problem here. It is therefore possible that
STONE ET AL. 11
the observed elevation in DBV could be of physiological origin. How-
ever, further work is required to establish the accuracy and repeatabil-
ity of this technique. From Figure 1 it can be seen that the error in
DBV can be quite high and from previous work it has been noted that
the accuracy of this measurement requires improvement (Stone &
Blockley, 2017).
4.9 | Group heterogeneity, flow, and further work
From the patient-level analysis (Figure 3), only the ischaemic core
[dHb] demonstrated a significantly different value from infarct growth
and contralateral ROIs. Although strict inclusion criteria were
employed in this study to provide a uniform patient cohort, the failure
to detect significant changes in R20 and DBV may be partly explained
by remaining heterogeneity in this group. Heterogeneity in regional
perfusion status is apparent, with almost equal numbers of patients
exhibiting hypo- and hyperperfusion in their presenting ischaemic
core ROIs. A further source of heterogeneity across the group may be
attributed to differences in onset to scan time (Table 1).
Alongside demonstrating the sensitivity of sqBOLD to changes in
oxygenation, this study provides a demonstration of how complemen-
tary measurements of flow and oxygenation can be used to provide a
unique insight into tissue viability. In practise, the information pro-
vided by sqBOLD could aid the interpretation of ASL CBF measure-
ments, since low flow does not always progress to infarction in
regions experiencing benign oligaemia (Kidwell, Alger, & Saver, 2003).
Although it is beyond the scope of this study, the combination of CBF
and [dHb] measurements allows for the calculation of the cerebral
metabolic rate of oxygen consumption (CMRO2) (Blockley, Griffeth,
Stone, Hare, & Bulte, 2015). This has been shown to improve tissue
outcome prediction and may partly explain the variability seen in the
presenting sqBOLD oxygenation measurements (An et al., 2015). The
ASL acquisition used in this study utilises multiple postlabelling delays
and as such offers improved accuracy of CBF quantification in the
case of delayed blood arrival times. However, care should be taken
when comparing these resuls with typical DSC PWI measurements
where TTP and MTT are often preferred.
The identification of tissue outcomes based solely on measure-
ments from this method does not currently appear to be possible, as
evidenced by the considerable overlap between tissue outcome distri-
butions in Figure 2. However, Kruskal–Wallis tests and post hoc pair-
wise comparisons found significant differences between these
distributions suggesting that tissue outcome is dependent on tissue
oxygenation and that the parameter maps derived from sqBOLD are
sensitive to identifying this information on presentation. As such,
sqBOLD provides complementary information to existing imaging
modalities such as DWI and ASL and the combination of this informa-
tion may allow for earlier identification of tissue under metabolic
stress during the acute phases of stroke (An et al., 2015).
Future development of sqBOLD should focus on improving the
robustness of the oxygenation measurements through refinement of
the sqBOLD acquisition, modelling and analysis routines. This work
would be aided by a study of the repeatability of the R20 measure-
ment. To date the only study to compare multiple techniques for mea-
suring R20 suggested that ASE has a marginally increased intersubject
standard deviation (Ni, Christen, Zun, & Zaharchuk, 2015). However,
it is difficult to compare these results with the current work, since the
acquisitions differ significantly, and therefore further investigation of
the GASE technique is warranted.
In addition, this study supports the further investigation of
sqBOLD in a larger scale study and highlights the importance of con-
trolling for onset to scan time and tissue perfusion status. The results
presented here provide an initial estimate of the effect size that may
be used to ensure follow on studies are adequately powered (Table 3).
The noninvasive, quantitative nature of this method also means it is
suitable for the longitudinal monitoring of stroke evolution and may
provide unique insight into the various pathways to infarction and
recovery, as well as providing valuable biomarkers with which to
assess treatment and intervention (Figure 8).
5 | CONCLUSION
Streamlined-qBOLD was used to acquire information about oxygen
metabolism in a cohort of acute ischaemic stroke patients, which is
complementary to conventional MRI methodologies. It was found that
resting brain oxygenation related parameters (R20, DBV, and [dHb])
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FIGURE 8 Comparison of measurements made during presenting and
1 week stroke-onset-to-scan-times (n = 6). For each parameter (R20,
DBV, [dHb], and CBF), measurements made in core and growth ROIs
are normalised to contralateral tissue and group averaged (± standard
deviation). Significant decreases in R20 were detected in both core
(p = 0.049) and growth (p = 0.006) after 1 week (paired t-test).
*p < 0.05 [Color figure can be viewed at wileyonlinelibrary.com]
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vary between regions with different tissue outcomes. The appropriate
implementation of R20 , DBV and [dHb] parameter maps has the poten-
tial to refine the identification of the ischaemic penumbra.
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